UK markets open in 3 hours 56 minutes

Kontafarma China Holdings Limited (1312.HK)

HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
0.038+0.003 (+8.57%)
As of 09:53AM HKT. Market open.
Currency in HKD

Valuation measures4

Market cap (intra-day) 195.60M
Enterprise value 441.76M
Trailing P/E 30.38
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.24
Price/book (mrq)0.19
Enterprise value/revenue 0.55
Enterprise value/EBITDA 5.63

Trading information

Stock price history

Beta (5Y monthly) 0.04
52-week change 3-27.08%
S&P500 52-week change 326.43%
52-week high 30.051
52-week low 30.026
50-day moving average 30.034
200-day moving average 30.035

Share statistics

Avg vol (3-month) 3496.14k
Avg vol (10-day) 3166.2k
Shares outstanding 55.59B
Implied shares outstanding 65.59B
Float 81.9B
% held by insiders 165.97%
% held by institutions 10.00%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 427 May 2013
Last split factor 25:1
Last split date 320 Jan 2015

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -3.56%
Operating margin (ttm)-14.39%

Management effectiveness

Return on assets (ttm)-3.00%
Return on equity (ttm)-5.51%

Income statement

Revenue (ttm)809.11M
Revenue per share (ttm)0.14
Quarterly revenue growth (yoy)-14.60%
Gross profit (ttm)N/A
EBITDA -49.83M
Net income avi to common (ttm)-28.84M
Diluted EPS (ttm)-0.010
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)87.66M
Total cash per share (mrq)0.02
Total debt (mrq)333.82M
Total debt/equity (mrq)31.44%
Current ratio (mrq)1.53
Book value per share (mrq)0.19

Cash flow statement

Operating cash flow (ttm)37.12M
Levered free cash flow (ttm)58.34M